Clinical Trial Update: Efficacy and Safety of Tripterygium Wilfordii in Patients With Rheumatoid Arthritis [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/Phase 3 clinical trial update evaluating the efficacy and safety of Tripterygium wilfordii in patients with rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Tripterygium wilfordii (Tripterygium wilfordii)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Arthritis, Rheumatoid | Phase 2, Phase 3 | Status: COMPLETED